Treatment of ruptured hepatocellular carcinoma

被引:67
|
作者
Tanaka A. [1 ]
Takeda R. [2 ]
Mukaihara S. [2 ]
Hayakawa K. [3 ]
Shibata T. [4 ]
Itoh K. [4 ]
Nishida N. [5 ]
Nakao K. [5 ]
Fukuda Y. [6 ]
Chiba T. [7 ]
Yamaoka Y. [8 ]
机构
[1] Department of Emergency Medicine, Kyoto University Hospital, Sakyo-ku, Kyoto 606-8507
[2] Department of Surgery, Kyoto City Hospital, Kyoto
[3] Department of Radiology, Kyoto City Hospital, Kyoto
[4] Department of Radiology, Graduate School of Medicine, Kyoto University, Kyoto
[5] Second Department of Internal Medicine, Graduate School of Medicine, Kyoto University, Kyoto
[6] Medical Technology College, Kyoto University, Kyoto
[7] Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto
[8] Department of Gastrointestinal Surgery, Graduate School of Medicine, Kyoto University, Kyoto
关键词
Hepatocellular carcinoma; Liver cirrhosis; Shock; Spontaneous rupture; Transcatheter arterial embolization;
D O I
10.1007/s10147-001-8030-z
中图分类号
学科分类号
摘要
Background. The problem of whether surgical or conservative treatment is indicated for ruptured hepatocellular carcinoma (HCC) has not been analyzed from the viewpoint of long-term development of hepatitis viral infection from liver fibrosis to liver cirrhosis. Although transcatheter arterial embolization (TAE) for hemostasis followed by two-stage hepatectomy has been established as the best treatment for ruptured HCC, there still remain difficulties in the treatment of some patients. Methods. Twelve patients with ruptured HCC who were surgically or conservatively treated were retrospectively analyzed in terms of modality of treatment, liver function, extension of HCC, complications, survival rate, and cause of death. Results. Tumor rupture can occur either in the early phase or in the terminal phase during the development from liver fibrosis to liver cirrhosis, while tumor rupture occurs at the advanced stage in terms of HCC extension. TAE for emergent hemostasis or prevention of re-bleeding was performed in ten patients, while TAE was contraindicated in one patient and emergent laparotomy for hemostasis was performed in one patient. In four patients, elective extended surgical resection was performed, because liver function was evaluated as clinical stage 1 according to the General rules for the clinical and pathological study of primary liver cancer of the Liver Cancer Study Group of Japan. In seven patients, conservative or medical treatment was selected, because liver function was evaluated as poor. The surgically treated group, who could tolerate extensive operation, survived longer than the conservatively treated group. Conclusions. While TAE remains the best method to employ for hemostasis, it still has limitations. Hence, we should be mindful of other possible modalities for hemostasis and their outcomes. Rupture of HCC at an early phase in the development of liver fibrosis is a good indication for elective surgical treatment and should be distinguished from rupture in the terminal phase of liver cirrhosis, which should be treated conservatively. Although elective surgical treatment can be performed in selected patients, tumor size and location of HCC, in addition to liver function, should be taken into consideration.
引用
下载
收藏
页码:291 / 295
页数:4
相关论文
共 50 条
  • [41] Ruptured hepatocellular carcinoma - experience in a tertiary centre
    Chin, J.
    Rao, S.
    Kontorinis, N.
    Jeffrey, G.
    Anderson, J.
    Cheng, W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 96 - 97
  • [42] Delayed hepatic resection for ruptured hepatocellular carcinoma
    Shuto, T
    Hirohashi, K
    Kubo, S
    Tanaka, H
    Hamba, H
    Kubota, D
    Kinoshita, H
    SURGERY, 1998, 124 (01) : 33 - 37
  • [43] The role of hyperthermic intraperitoneal chemotherapy in the treatment of spontaneously ruptured hepatocellular carcinoma: a pilot study
    Ruan, Shiye
    Shi, Ning
    Chen, Zhihong
    Han, Hongwei
    Wang, Hanyue
    Jin, Liang
    Zou, Yiping
    Zhang, Yuanpeng
    Yu, Min
    Jin, Haosheng
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (18)
  • [44] Ruptured hepatocellular carcinoma following chemoembolization:a western experience
    Narendra Battula
    Parthi Srinivasan
    Mansoor Madanur
    Srinivas Prabhu Chava
    Oliver Priest
    Mohamed Rela
    Nigel Heaton
    Hepatobiliary & Pancreatic Diseases International, 2007, (01) : 49 - 51
  • [45] Hepatocellular carcinoma that ruptured during radiofrequency ablation therapy
    Toshihiko Kawasaki
    Masatoshi Kudo
    Hobyung Chung
    Yasunori Minami
    Journal of Gastroenterology, 2004, 39 : 1015 - 1016
  • [46] Ruptured hepatocellular carcinoma following chemoembolization: a western experience
    Battula, Narendra
    Srinivasan, Parthi
    Madanur, Mansoor
    Chava, Srinivas Prabhu
    Priest, Oliver
    Rela, Mohamed
    Heaton, Nigel
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2007, 6 (01) : 49 - 51
  • [47] Outcomes and Prognostic Factors of Spontaneously Ruptured Hepatocellular Carcinoma
    Zhang, Wei
    Zhang, Zhi-Wei
    Zhang, Bi-Xiang
    Huang, Zhi-Yong
    Zhang, Wan-Guang
    Liang, Hui-Fang
    Chen, Xiao-Ping
    JOURNAL OF GASTROINTESTINAL SURGERY, 2019, 23 (09) : 1788 - 1800
  • [48] Outcomes and Prognostic Factors of Spontaneously Ruptured Hepatocellular Carcinoma
    Wei Zhang
    Zhi-Wei Zhang
    Bi-Xiang Zhang
    Zhi-Yong Huang
    Wan-Guang Zhang
    Hui-Fang Liang
    Xiao-Ping Chen
    Journal of Gastrointestinal Surgery, 2019, 23 : 1788 - 1800
  • [49] LONG-TERM OUTCOMES OF RUPTURED HEPATOCELLULAR CARCINOMA
    Harris, Kevin B.
    Nimri, Faisal M.
    Salgia, Reena J.
    HEPATOLOGY, 2023, 78 : S1860 - S1861
  • [50] Findings of ruptured hepatocellular carcinoma on computed tomography in Thailand
    Kittijanikhajorn, Mayuree
    Tantivatana, Jaturon
    Vajragupta, Laddawan
    ASIAN BIOMEDICINE, 2007, 1 (03) : 289 - 294